Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis. - Wikidata - awgldk - TriplyDB

Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.

Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.

http://www.wikidata.org/entity/Q33374004

about

Autoantigen Microarray for High-throughput Autoantibody Profiling in Systemic Lupus Erythematosus A model for lupus brain disease Anti-NR2A/B Antibodies and Other Major Molecular Mechanisms in the Pathogenesis of Cognitive Dysfunction in Systemic Lupus Erythematosus Biomarkers for CNS involvement in pediatric lupus Lupus brain fog: a biologic perspective on cognitive impairment, depression, and fatigue in systemic lupus erythematosus Anti-U1 RNP antibodies in cerebrospinal fluid are associated with central neuropsychiatric manifestations in systemic lupus erythematosus and mixed connective tissue disease Estrogen receptor alpha modulates Toll-like receptor signaling in murine lupus The MRL/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosus.Neurotoxic autoantibodies mediate congenital cortical impairment of offspring in maternal lupus.Neuropsychiatric Lupus, the Blood Brain Barrier, and the TWEAK/Fn14 Pathway.Evaluation of magnetic resonance imaging abnormalities in juvenile onset neuropsychiatric systemic lupus erythematosus Anti-alpha-internexin autoantibody from neuropsychiatric lupus induce cognitive damage via inhibiting axonal elongation and promote neuron apoptosis.Glutamate receptor biology and its clinical significance in neuropsychiatric systemic lupus erythematosus.Blood-brain barrier damages and intrathecal synthesis of anti-N-methyl-D-aspartate receptor NR2 antibodies in diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus.Antibodies against N-methyl-D-aspartate receptors in patients with systemic lupus erythematosus without major neuropsychiatric syndromes.Antibodies and the Brain: Lessons from Lupus.Neurocognitive dysfunction in systemic lupus erythematosus: association with antiphospholipid antibodies, disease activity and chronic damage.Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms.Peptides and peptidomimetics as immunomodulators.Evaluation and treatment of chronic meningitis.Estrogen receptor alpha deficiency protects against development of cognitive impairment in murine lupus.Moving towards a cure: blocking pathogenic antibodies in systemic lupus erythematosus.Lessons from an anti-DNA autoantibody.Generation of a unique small molecule peptidomimetic that neutralizes lupus autoantibody activity.Brain metabolism and autoantibody titres predict functional impairment in systemic lupus erythematosus.Brain-reactive antibodies and disease.Autoantibody profiling on human proteome microarray for biomarker discovery in cerebrospinal fluid and sera of neuropsychiatric lupus Differences in regional brain activation patterns assessed by functional magnetic resonance imaging in patients with systemic lupus erythematosus stratified by disease duration Selective Impairment of Spatial Cognition Caused by Autoantibodies to the N-Methyl-D-Aspartate Receptor.Neuropsychiatric systemic lupus erythematosus persists despite attenuation of systemic disease in MRL/lpr mice.Integrative neuroscience approach to neuropsychiatric lupus Losing your nerves? Maybe it's the antibodies.Non-pathogenic tissue-resident CD8+ T cells uniquely accumulate in the brains of lupus-prone mice.Neuropsychiatric manifestations in systemic lupus erythematosus: epidemiology, pathophysiology and management.Systemic lupus erythematosus, the brain, and anti-NR2 antibodies.Cognitive and emotional abnormalities in systemic lupus erythematosus: evidence for amygdala dysfunction.Possible novel biomarkers of organ involvement in systemic lupus erythematosus.Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic review.Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers.Role of Inflammation in Suicide: From Mechanisms to Treatment.

P2860

Q26785472-8F27BAAD-DA97-4F5C-95A0-4620FE2BD599 Q26824461-5FCA6161-CA7D-4062-AE3C-5302A169FC2E Q26996498-82A2B59A-27B9-4203-A2FB-D2021E35220C Q28082493-DE1CEA53-CA16-4A2A-B73B-E0656BD806B8 Q28268802-FDBEBAA3-7BC6-41F9-809B-9DB4EE87F05B Q28290942-BDD4CDE3-1C5D-43E6-9BBB-7BF2CA3FF883 Q28583551-044F2EEE-6600-434B-BCFD-AC3891F8CC75 Q30476952-E39F3C23-8488-426A-A029-D2564CEF191A Q30485404-BB234CCD-8E1F-4F8C-9056-63F9A16CB1A1 Q30727936-F541CA41-BF8D-495A-A6C6-0CD50183A9CB Q31121775-CEB1854A-A183-4726-BCDF-54DA62BFE1E8 Q33608727-B487324F-D11D-4A04-8893-ACF141F8F833 Q33723529-B072D067-968B-430E-96DC-E7F855962000 Q33765429-750B8C43-296F-4511-AB31-378DDAA9D476 Q34059923-61BC9713-6F66-48A2-BCFF-4BB22EBD2C4D Q34201906-3AD0EC79-395F-4309-A450-F720304C0400 Q34213820-33A5A353-269E-4B3A-B52F-D64C5E948859 Q34276891-573F939F-D2FC-4EF9-B2DD-1EFE4FA767B9 Q34359984-72948914-5003-4009-AF9E-E4A445F6FC3F Q34418500-8AFAEFCA-A638-4F7D-9C45-BDA4748CB93A Q34746630-BE327D21-E9E7-4505-BF81-888795539175 Q34753885-CAFE798F-FC74-4FD7-B44A-2B8435A377F7 Q35013745-8A5F2454-FB37-48D6-B9CC-54C2E511C427 Q35064255-04755E07-D998-45CE-8C1A-DE4651B7F662 Q35233633-BBBAAC85-877B-49CE-B488-56074E51DF76 Q35458567-0D216991-EA12-4FC0-B7C7-BCD5E18367AE Q35625134-904292C7-8C4C-4971-ABED-4C22A80C99B3 Q35876838-FD60E058-9A23-433F-B14D-D551F1D6A4ED Q35947538-821C0581-44C5-48EC-8A5A-A248D272BCBD Q36259188-41FED14C-03B7-4758-B9ED-BA19E822958D Q37032127-80AA0F75-4ED0-4624-B63E-943576E36350 Q37440005-1E8F96F7-4280-4263-BFB9-EC7C543B9AB2 Q37591123-B75F4F00-ED10-4B59-BB26-FBA6D4AFB120 Q37922765-8EC740AC-F725-4A66-8EFB-2874D810F546 Q37930475-9133FBF9-1D2D-4BFA-A4EE-BE112B7CAA5B Q38034111-7BF6AD8B-24E2-4E52-9D0A-21B8F1E999A5 Q38193734-E0CBD777-A0F5-4FA0-87A9-2BEBB821CABF Q38222127-4F1FCEE2-D0F4-481C-9E57-651A91FA83F9 Q38247180-F121DF44-E244-45DD-8A28-D5583AEB8B03 Q38885617-C29E50ED-89AE-49B4-B46B-2E115E0417F3

P2860

Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.

http://www.wikidata.org/entity/Q33374004

description

2008 nî lūn-bûn

@nan

2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Serum and cerebrospinal fluid ...... or diagnosis and pathogenesis.

@ast

Serum and cerebrospinal fluid ...... or diagnosis and pathogenesis.

@en

type

label

Serum and cerebrospinal fluid ...... or diagnosis and pathogenesis.

@ast

Serum and cerebrospinal fluid ...... or diagnosis and pathogenesis.

@en

prefLabel

Serum and cerebrospinal fluid ...... or diagnosis and pathogenesis.

@ast

Serum and cerebrospinal fluid ...... or diagnosis and pathogenesis.

@en

P1433

Q33374004-6044EAF1-FE4D-4559-B2B9-AD4B41C85191

P1476

Q33374004-AB6226D3-F89A-4C77-8D44-105B629DAD86

P2093

Q33374004-0B17F54D-D5F8-44F9-8BFA-822516941DC5

Q33374004-5885F2C8-646E-471C-8322-5FA5E1E569ED

Q33374004-7C341BB0-3E25-47CD-949D-1E0FD0FAEA10

Q33374004-97C27C26-608E-4057-BED3-45EE1402B59F

Q33374004-E1042C86-ECEB-4F50-8F7E-9E3C771AAC45

Q33374004-E30AF2A6-5326-42CF-A020-A31EA1947211

Q33374004-E6AA5C09-7050-48DE-8B72-22E476E9E84B

Q33374004-F6EF2D62-C3E0-46DD-A825-686B2BDD62E0

P2860

Q33374004-10267CA8-4914-47AB-BA0B-52455FA50B2A

Q33374004-11025472-4D7B-456E-B2C7-91AF2CDDB6DE

Q33374004-1346E342-DD04-4FBE-B2C5-D604DD62C6D0

Q33374004-1EE6DC07-FDBC-405B-966B-551F9B1B3988

Q33374004-22C4996A-AAED-4559-BECA-DBE8A3693F59

Q33374004-3EF9045F-938D-4A77-9D6B-9D3FE8CF1378

Q33374004-5D610E76-5A20-4D64-936C-5BBDCEE62A77

Q33374004-65531E16-274D-4946-8A0E-469810C3F907

Q33374004-678D551A-7659-45F0-B2D7-EB71E4B75EAF

Q33374004-68E048D2-0AA4-46B1-B7B4-CC6A151B4563

P304

Q33374004-EB345C9F-6169-4C09-A9D4-D9105F0E1246

P31

Q33374004-00C8CC67-C88B-4B09-9D30-88544FBD9839

P356

Q33374004-A7E7BDFE-0E8D-482D-AD20-8FE12853B832

P407

Q33374004-B94F49EA-B070-4ACD-8D8F-076CC9F37A2B

P433

Q33374004-D455F691-0485-4E13-8F18-3BE606EEC8D7

P478

Q33374004-A734ED77-4072-40E3-9203-933C50DF6AFF

P577

Q33374004-429AA192-CD15-4C75-8F8E-DAA767832D4A

P5875

Q33374004-B92A02D1-0D69-4A06-AF4B-A423B3CA9E70

P698

Q33374004-623B45F5-BDF3-4C24-B9A3-AA49698B99BF

P921

Q33374004-1B84DDC2-7C37-4A7A-AD77-C82B91057499

Q33374004-D48CC1EE-F933-4142-894E-40184E0DBFC2

P932

Q33374004-E0588650-E899-4DFC-A187-66E957A151C4

P356

JOURNAL.PONE.0003347

P1433

P1476

Serum and cerebrospinal fluid ...... or diagnosis and pathogenesis.

@en

P2093

Alejandro Orozco-Narváez

http://www.w3.org/2001/XMLSchema#string

Betty Diamond

http://www.w3.org/2001/XMLSchema#string

Hilda Fragoso-Loyo

http://www.w3.org/2001/XMLSchema#string

Javier Cabiedes

http://www.w3.org/2001/XMLSchema#string

Jorge Sánchez-Guerrero

http://www.w3.org/2001/XMLSchema#string

Luis Dávila-Maldonado

http://www.w3.org/2001/XMLSchema#string

Luis Llorente

http://www.w3.org/2001/XMLSchema#string

Yemil Atisha-Fregoso

http://www.w3.org/2001/XMLSchema#string

P2860

The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting

The 1982 revised criteria for the classification of systemic lupus erythematosus

The blood-brain barrier/neurovascular unit in health and disease

The blood-brain barrier in systemic lupus erythematosus.

Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort.

Cognition, MRS neurometabolites, and MRI volumetrics in non-neuropsychiatric systemic lupus erythematosus: preliminary data.

Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura.

Nicotine increases in vivo blood-brain barrier permeability and alters cerebral microvascular tight junction protein distribution.

The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus.

The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation.

P304

e3347

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0003347

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23301033

http://www.w3.org/2001/XMLSchema#string

P698

18836530

http://www.w3.org/2001/XMLSchema#string

P921

cerebrospinal fluid

P932

2556096

http://www.w3.org/2001/XMLSchema#string